pentetic acid has been researched along with Liver Dysfunction in 50 studies
Pentetic Acid: An iron chelating agent with properties like EDETIC ACID. DTPA has also been used as a chelator for other metals, such as plutonium.
Excerpt | Relevance | Reference |
---|---|---|
"The potential to define liver tumors at magnetic resonance (MR) imaging was compared with a positive and a negative contrast agent (gadoxetic acid disodium, or gadolinium EOB-DTPA [a hepatocyte-directed agent], and ferumoxides, or superpara-magnetic iron oxide particles [a Kupffer cell-directed agent], respectively) in normal rats and in rats with induced acute hepatitis, fatty liver, or cirrhosis." | 3.69 | Definition of liver tumors in the presence of diffuse liver disease: comparison of findings at MR imaging with positive and negative contrast agents. ( Berthezene, Y; Brasch, RC; Cohen, F; Kuwatsuru, R; Mathur, A; Mintorovitch, J; Mühler, A; Rosenau, W; Shames, DM; Vexler, VS, 1997) |
" A comparison of gadopentetate dimeglumine-enhanced FMPSPGR images with spin-echo T1- and T2-weighted images showed a superior contrast-to-noise ratio for the enhanced FMPSPGR images in 17 (68%) of 25 hepatic lesions, which included all hepatic cysts (n = 3) and all hepatomas (n = 6), and in six of 12 patients with other liver tumors." | 3.68 | Fast multiplanar spoiled gradient-recalled imaging of the liver: pulse sequence optimization and comparison with spin-echo MR imaging. ( Foo, TK; Francis, IR; Glazer, GM; Herfkens, RJ; Jeffrey, RB; Low, RN; Pelc, NJ; Shimakawa, A, 1993) |
" Changes in liver signal intensity, lesion-liver contrast-to-noise ration (C/N), detectable liver lesions, side effects, and adverse events were evaluated." | 2.68 | Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence. ( Balzer, T; Berns, T; Daldrup, HE; Hesse, T; Peters, PE; Reimer, P; Rummeny, EJ; Shamsi, K; Tombach, B, 1996) |
"In the dynamic T2-weighted sequences, hepatocellular carcinoma nodules (n = 4) showed a rapid decrease in signal intensity starting at 44 seconds." | 2.68 | Magnetic resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide resovist versus gadolinium-DTPA in the same patient. ( Balzer, JO; Balzer, T; Bechstein, WO; Felix, R; Hammerstingl, R; Kümmel, S; Lauten, MJ; Mack, MG; Müller, PK; Neuhaus, P; Schimpfky, C; Schrem, H; Schwarz, W; Vogl, TJ, 1996) |
"Thorium ((232)Th, IV) preferentially accumulates in the liver, femur and spleen, which necessitates evaluation of its toxic effect in these organs." | 1.35 | Thorium-induced oxidative stress mediated toxicity in mice and its abrogation by diethylenetriamine pentaacetate. ( Ali, M; Ghosh, S; Kumar, A; Mishra, KP; Mishra, P; Pandey, BN; Sharma, P, 2008) |
" Contrast agents were injected according to the currently recommended practices; Gd-DTPA was injected as a rapid bolus injection in a dosage of 0." | 1.29 | Enhancement of the normal pancreas: comparison of manganese-DPDP and gadolinium chelate. ( Brown, ED; Eisenberg, LB; Kettritz, U; Schlund, JF; Semelka, RC; Warshauer, DM, 1996) |
"Among ambulatory patients, Crohn's disease subjects, but not ulcerative colitis patients, had greater urinary recovery than the controls (P less than 0." | 1.28 | Intestinal permeability in gastrointestinal disorders. Use of oral [99mTc]DTPA. ( Barron, R; Marshall, W; Resnick, RH; Royal, H; Werth, T, 1990) |
"Focal nodular hyperplasia is characterised by very rapid signal enhancement within the first minute after contrast injection." | 1.28 | [Dynamic MR tomography of intrahepatic tumors]. ( Felix, R; Hamm, B; Wolf, KJ, 1989) |
" Two dosage schedules of the contrast medium (0." | 1.27 | [Magnetic resonance tomography of focal hepatic lesions using the para-magnetic contrast medium, gadolinium DTPA. First clinical results]. ( Felix, R; Hamm, B; Römer, T; Wolf, KJ, 1986) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 10 (20.00) | 18.7374 |
1990's | 38 (76.00) | 18.2507 |
2000's | 1 (2.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (2.00) | 2.80 |
Authors | Studies |
---|---|
Nakajima, K | 1 |
Seki, M | 1 |
Hatakeyama, S | 1 |
Arai, S | 1 |
Asami, Y | 1 |
Tanaka, K | 1 |
Ikeda, K | 1 |
Shimoyama, S | 1 |
Kobayashi, T | 1 |
Miyamoto, T | 1 |
Okada, Y | 1 |
Arakawa, H | 1 |
Takizawa, T | 1 |
LLOYD, HM | 1 |
POWELL, LW | 1 |
THOMAS, MJ | 1 |
Kumar, A | 1 |
Mishra, P | 1 |
Ghosh, S | 1 |
Sharma, P | 1 |
Ali, M | 1 |
Pandey, BN | 1 |
Mishra, KP | 1 |
Manfredi, R | 1 |
Maresca, G | 1 |
De Gaetano, AM | 1 |
De Franco, A | 1 |
Marano, P | 1 |
Brown, JJ | 2 |
Borrello, JA | 2 |
Raza, HS | 1 |
Balfe, DM | 1 |
Baer, AB | 1 |
Pilgram, TK | 2 |
Atilla, S | 2 |
Yamashita, Y | 1 |
Hatanaka, Y | 1 |
Yamamoto, H | 1 |
Arakawa, A | 1 |
Matsukawa, T | 1 |
Miyazaki, T | 1 |
Takahashi, M | 1 |
Mathur, S | 1 |
Flora, SJ | 1 |
Mathur, R | 1 |
Das Gupta, S | 1 |
Mühler, A | 4 |
Heinzelmann, I | 1 |
Weinmann, HJ | 1 |
Galati, JS | 2 |
Holdeman, KP | 2 |
Dalrymple, GV | 1 |
Harrison, KA | 1 |
Quigley, EM | 2 |
Rodgers, PM | 1 |
Ward, J | 4 |
Baudouin, CJ | 1 |
Ridgway, JP | 1 |
Robinson, PJ | 4 |
Hamm, B | 3 |
Thoeni, RF | 1 |
Gould, RG | 1 |
Bernardino, ME | 1 |
Lüning, M | 1 |
Saini, S | 2 |
Mahfouz, AE | 1 |
Taupitz, M | 1 |
Wolf, KJ | 3 |
Low, RN | 1 |
Francis, IR | 1 |
Herfkens, RJ | 1 |
Jeffrey, RB | 1 |
Glazer, GM | 1 |
Foo, TK | 1 |
Shimakawa, A | 1 |
Pelc, NJ | 1 |
Clément, O | 2 |
Saeed, M | 1 |
Lake, JR | 1 |
Stites, DP | 1 |
Berthezène, Y | 3 |
Brasch, RC | 3 |
Mitchell, DG | 3 |
Ortega, H | 1 |
Mohamed, F | 1 |
Tascyian, T | 1 |
Vinitski, S | 1 |
Martinéz, D | 1 |
Chalmers, AG | 1 |
Ridgway, J | 1 |
Smith, MA | 1 |
Kinnard, MF | 1 |
Alavi, A | 1 |
Rubin, RA | 1 |
Lichtenstein, GR | 1 |
Reimer, P | 3 |
Rummeny, EJ | 3 |
Shamsi, K | 2 |
Balzer, T | 4 |
Daldrup, HE | 1 |
Tombach, B | 2 |
Hesse, T | 2 |
Berns, T | 2 |
Peters, PE | 3 |
Vogl, TJ | 3 |
Kümmel, S | 2 |
Hammerstingl, R | 3 |
Schellenbeck, M | 1 |
Schumacher, G | 1 |
Schwarz, W | 2 |
Müller, PK | 2 |
Bechstein, WO | 2 |
Mack, MG | 2 |
Söllner, O | 1 |
Felix, R | 4 |
Giovagnoni, A | 1 |
Paci, E | 1 |
Gervais, DA | 1 |
Hahn, PF | 1 |
Goldberg, MA | 1 |
Weiskoff, R | 1 |
Yoshioka, H | 1 |
Itai, Y | 1 |
Onaya, H | 1 |
Doy, M | 1 |
Mitsumori, F | 1 |
Kettritz, U | 2 |
Warshauer, DM | 1 |
Brown, ED | 1 |
Schlund, JF | 2 |
Eisenberg, LB | 2 |
Semelka, RC | 2 |
Daldrup, H | 1 |
Sander, G | 1 |
Ito, K | 1 |
Honjo, K | 1 |
Fujita, T | 1 |
Awaya, H | 1 |
Takano, K | 1 |
Koike, S | 1 |
Matsumoto, T | 1 |
Matsunaga, N | 1 |
Lauten, MJ | 1 |
Balzer, JO | 1 |
Schimpfky, C | 1 |
Schrem, H | 1 |
Neuhaus, P | 1 |
Kuwatsuru, R | 2 |
Mathur, A | 1 |
Vexler, VS | 2 |
Rosenau, W | 2 |
Mintorovitch, J | 1 |
Cohen, F | 1 |
Shames, DM | 1 |
Earls, JP | 1 |
Rofsky, NM | 1 |
DeCorato, DR | 1 |
Krinsky, GA | 1 |
Weinreb, JC | 1 |
Naik, KS | 1 |
Irving, HC | 1 |
Wilbur, K | 1 |
Blakeborough, A | 1 |
Wilson, D | 1 |
Griffiths, M | 1 |
Kajiya, Y | 1 |
Guthrie, JA | 1 |
Quillin, SP | 1 |
Yu, CY | 1 |
Ichikawa, T | 1 |
Haradome, H | 1 |
Hachiya, J | 1 |
Nitatori, T | 1 |
Araki, T | 1 |
Bottjen, PL | 1 |
Park, HM | 1 |
Archer, E | 1 |
Schnell, B | 1 |
Eibl-Eibesfeldt, B | 1 |
Peqios, W | 1 |
Lissner, J | 2 |
Runge, VM | 1 |
Vogl, T | 1 |
Steiner, S | 1 |
Hahn, D | 1 |
Schedel, H | 1 |
Pavone, P | 1 |
Giuliani, S | 1 |
Cardone, G | 1 |
Occhiato, R | 1 |
Di Renzi, P | 1 |
Petroni, GA | 1 |
Buoni, C | 1 |
Passariello, R | 1 |
Resnick, RH | 1 |
Royal, H | 1 |
Marshall, W | 1 |
Barron, R | 1 |
Werth, T | 1 |
Edelman, RR | 1 |
Siegel, JB | 1 |
Singer, A | 1 |
Dupuis, K | 1 |
Longmaid, HE | 1 |
Römer, T | 1 |
Yoshida, H | 1 |
Mano, I | 1 |
Gotoh, H | 1 |
Miyagawa, S | 1 |
Nakabayashi, K | 1 |
Yashiro, N | 1 |
Iio, M | 1 |
Barry, M | 1 |
Sherlock, S | 1 |
Jaiswal, DK | 1 |
Chander, J | 1 |
Malik, A | 1 |
Singh, B | 1 |
Scuro, LA | 1 |
Mardell, R | 1 |
Welch, MJ | 1 |
4 reviews available for pentetic acid and Liver Dysfunction
Article | Year |
---|---|
Nuclear imaging of solid hepatic masses.
Topics: Algorithms; Carcinoma, Hepatocellular; Costs and Cost Analysis; Hemangioma, Cavernous; Humans; Indiu | 1995 |
Liver I: Currently available gadolinium chelates.
Topics: Contrast Media; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Liver; Liver Diseases; | 1996 |
Liver. III: Gadolinium-based hepatobiliary contrast agents (Gd-EOB-DTPA and Gd-BOPTA/Dimeg).
Topics: Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Contrast Media; Female; Gadol | 1996 |
[Status and development of new clinical contrast media for MR diagnosis of liver diseases].
Topics: Acetates; Contrast Media; Edetic Acid; Gadolinium DTPA; Humans; Liver Diseases; Liver Neoplasms; Mag | 1992 |
5 trials available for pentetic acid and Liver Dysfunction
Article | Year |
---|---|
Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence.
Topics: Contrast Media; Dose-Response Relationship, Drug; Double-Blind Method; Female; Gadolinium; Gadoliniu | 1996 |
Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Double-Blind Method | 1996 |
Magnetic resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide resovist versus gadolinium-DTPA in the same patient.
Topics: Carcinoma, Hepatocellular; Contrast Media; Dextrans; Ferrosoferric Oxide; Follow-Up Studies; Gadolin | 1996 |
Comparison of dynamic contrast enhanced MRI and Doppler ultrasound in the pre-operative assessment of the portal venous system.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Contrast Media; Female; Gadolinium DTPA; Hepatecto | 1997 |
[Magnetic resonance tomography of the hepatobiliary system: indications, limitations and outlook].
Topics: Biliary Tract Diseases; Biliary Tract Neoplasms; Cholangiography; Contrast Media; Edetic Acid; Gadol | 1992 |
41 other studies available for pentetic acid and Liver Dysfunction
Article | Year |
---|---|
Visual liver assessment using Gd-EOB-DTPA-enhanced magnetic resonance imaging of patients in the early post-Fontan period.
Topics: Child; Child, Preschool; Female; Gadolinium; Humans; Liver Diseases; Magnetic Resonance Imaging; Mal | 2020 |
IDIOPATHIC HAEMOCHROMATOSIS IN MENSTRUATING WOMEN. A FAMILY STUDY, INCLUDING THE USE OF DIETHYLENE TRIAMINE PENTA-ACETIC ACID.
Topics: Acetic Acid; Biopsy; Blood Chemical Analysis; Chelating Agents; Diabetes Mellitus; Female; Genetics, | 1964 |
Thorium-induced oxidative stress mediated toxicity in mice and its abrogation by diethylenetriamine pentaacetate.
Topics: Animals; Female; Iron Chelating Agents; Liver Diseases; Mice; Oxidative Stress; Pentetic Acid; Radia | 2008 |
[The tissue characterization of focal liver lesions with magnetic resonance imaging].
Topics: Biopsy, Needle; Contrast Media; Diagnosis, Differential; Gadolinium; Gadolinium DTPA; Humans; Hyperp | 1995 |
Dynamic contrast-enhanced MR imaging of the liver: parenchymal enhancement patterns.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Gadolinium DTPA; Humans; Liver; Liver Diseas | 1995 |
Differential diagnosis of focal liver lesions: role of spin-echo and contrast-enhanced dynamic MR imaging.
Topics: Contrast Media; Diagnosis, Differential; Drug Combinations; Female; Gadolinium DTPA; Humans; Liver; | 1994 |
Mobilization and distribution of beryllium over the course of chelation therapy with some polyaminocarboxylic acids in the rat.
Topics: Animals; Berylliosis; Beryllium; Chelating Agents; Chelation Therapy; Chemical and Drug Induced Live | 1993 |
Elimination of gadolinium-ethoxybenzyl-DTPA in a rat model of severely impaired liver and kidney excretory function. An experimental study in rats.
Topics: Animals; Bile; Contrast Media; Female; Gadolinium DTPA; Kidney Diseases; Liver Diseases; Organometal | 1994 |
Delayed gastric emptying of both the liquid and solid components of a meal in chronic liver disease.
Topics: Adult; Chronic Disease; Female; Food; Gastric Emptying; Humans; Hypertension, Portal; Indium Radiois | 1994 |
Dynamic contrast-enhanced MR imaging of the portal venous system: comparison with x-ray angiography.
Topics: Adolescent; Adult; Child; Child, Preschool; Contrast Media; Drug Combinations; Female; Gadolinium DT | 1994 |
Focal liver lesions: characterization with nonenhanced and dynamic contrast material-enhanced MR imaging.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Diagnosis, Differential; Drug Combinations; Female; | 1994 |
Fast multiplanar spoiled gradient-recalled imaging of the liver: pulse sequence optimization and comparison with spin-echo MR imaging.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Cysts; Drug Combinations; Female; Gadolinium | 1993 |
Gadolinium-ethoxybenzyl-DTPA, a new liver-directed magnetic resonance contrast agent. Absence of acute hepatotoxic, cardiovascular, or immunogenic effects.
Topics: Animals; Bile; Contrast Media; Enzyme-Linked Immunosorbent Assay; Female; Gadolinium DTPA; Hemodynam | 1993 |
Aortic ghost artifact in ultrashort TE multislice gradient echo MR images is not increased by paramagnetic enhancement.
Topics: Aorta, Abdominal; Artifacts; Contrast Media; Drug Combinations; Gadolinium; Gadolinium DTPA; Humans; | 1993 |
Rapid dynamic contrast-enhanced magnetic resonance imaging of the liver and portal vein.
Topics: Gadolinium DTPA; Hepatic Artery; Hepatic Veins; Humans; Liver; Liver Diseases; Liver Neoplasms; Magn | 1993 |
Gadolinium-DTPA enhanced echoplanar MR imaging of the liver: preliminary observations.
Topics: Contrast Media; Echo-Planar Imaging; Gadolinium DTPA; Humans; Liver Diseases; Organometallic Compoun | 1996 |
MR imaging of non-cancerous hepatic lesions in Long-Evans cinnamon rats.
Topics: Animals; Contrast Media; Gadolinium DTPA; Liver; Liver Diseases; Magnetic Resonance Imaging; Male; O | 1996 |
Enhancement of the normal pancreas: comparison of manganese-DPDP and gadolinium chelate.
Topics: Adipose Tissue; Adult; Aged; Contrast Media; Edetic Acid; Female; Gadolinium; Gadolinium DTPA; Human | 1996 |
[New MR contrast media in liver diagnosis. Initial clinical results with hepatobiliary Eovist (gadolinium-EOB-DTPA) and RES-specific Resovist (SH U 555 A)].
Topics: Contrast Media; Dextrans; Dose-Response Relationship, Drug; Female; Ferrosoferric Oxide; Gadolinium | 1996 |
Gadolinium-enhanced MR imaging of the spleen: artifacts and potential pitfalls.
Topics: Aged; Artifacts; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Ima | 1996 |
Definition of liver tumors in the presence of diffuse liver disease: comparison of findings at MR imaging with positive and negative contrast agents.
Topics: Acute Disease; Animals; Contrast Media; Dextrans; Fatty Liver; Female; Ferrosoferric Oxide; Gadolini | 1997 |
Hepatic arterial-phase dynamic gadolinium-enhanced MR imaging: optimization with a test examination and a power injector.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Contrast Media; Drug Combinations; Female; Gadolinium; G | 1997 |
Comparison of gadolinium chelates with manganese-DPDP for liver lesion detection and characterization: preliminary results.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Cysts; Edetic Acid; Female; Gadolinium; Gado | 1996 |
Hepatic lesion detection at MR imaging: a comparative study with four sequences.
Topics: Adipose Tissue; Adult; Aged; Area Under Curve; Contrast Media; Drug Combinations; Female; Ferrosofer | 1997 |
Characterization of focal hepatic masses by dynamic contrast-enhanced MR imaging: findings in 311 lesions.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Cysts; Drug C | 1997 |
Perfusion-weighted MR imaging in the upper abdomen: preliminary clinical experience in 61 patients.
Topics: Abdomen; Adult; Aged; Contrast Media; Drug Combinations; Echo-Planar Imaging; Female; Gadolinium DTP | 1997 |
Gastric emptying and orocecal transit in portal hypertension and end-stage chronic liver disease.
Topics: Adult; Aged; Breath Tests; Estradiol; Female; Gastric Emptying; Gastrointestinal Transit; Humans; Hy | 1997 |
Hepatic emboli following inferior vena caval ligation. Brief report.
Topics: Adult; Embolism; Humans; Liver Diseases; Male; Pentetic Acid; Postoperative Complications; Radionucl | 1977 |
Evaluation of radiation-induced liver injury with MR imaging: comparison of hepatocellular and reticuloendothelial contrast agents.
Topics: Animals; Dextrans; Female; Ferrosoferric Oxide; Gadolinium DTPA; Iron; Liver; Liver Diseases; Magnet | 1992 |
Magnetic resonance imaging contrast agents.
Topics: Abdomen; Animals; Brain Diseases; Contrast Media; Drug Combinations; Gadolinium; Gadolinium DTPA; He | 1992 |
[Diffuse liver parenchymal diseases: the value of MRI compared to sonography and CT].
Topics: Contrast Media; Diagnosis, Differential; Evaluation Studies as Topic; Gadolinium; Gadolinium DTPA; H | 1991 |
Intraarterial portography with gadopentetate dimeglumine: improved liver-to-lesion contrast in MR imaging.
Topics: Adult; Aged; Female; Gadolinium DTPA; Humans; Injections, Intra-Arterial; Liver; Liver Diseases; Mag | 1991 |
Intestinal permeability in gastrointestinal disorders. Use of oral [99mTc]DTPA.
Topics: Administration, Oral; Biliary Tract Diseases; Colitis, Ulcerative; Crohn Disease; Gastrointestinal D | 1990 |
[Dynamic MR tomography of intrahepatic tumors].
Topics: Adult; Aged; Contrast Media; Cysts; Gadolinium; Gadolinium DTPA; Hemangioma; Humans; Hyperplasia; Li | 1989 |
Dynamic MR imaging of the liver with Gd-DTPA: initial clinical results.
Topics: Contrast Media; Gadolinium DTPA; Humans; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance | 1989 |
[Magnetic resonance tomography of focal hepatic lesions using the para-magnetic contrast medium, gadolinium DTPA. First clinical results].
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Female; Gadolinium; Gadol | 1986 |
[Magnetic resonance imaging of hepatic tumors using a rapid pulse sequence method].
Topics: Carcinoma, Hepatocellular; Cysts; Female; Gadolinium; Hemangioma; Humans; Liver Diseases; Liver Neop | 1987 |
Measurement of liver-iron concentration in needle-biopsy specimens.
Topics: Adolescent; Adult; Chronic Disease; Female; Humans; Iron; Liver; Liver Diseases; Male; Metal Metabol | 1971 |
Paper chromatography of 113m In-labelled radiopharmaceuticals: (113m In) DTPA.
Topics: Brain Diseases; Chromatography, Paper; Female; Indium; Isotope Labeling; Liver Diseases; Methods; Pe | 1973 |
[Diagnostic value of some iron metabolic parameters in acute and chronic liver diseases].
Topics: Adolescent; Adult; Aged; Autoradiography; Binding Sites; Deferoxamine; Humans; Iron; Iron Chelating | 1971 |
Chemistry, common sense and indium scanning agents.
Topics: Brain Diseases; Chemical Phenomena; Chemistry; Drug Compounding; Indium; Liver Diseases; Methods; Pe | 1970 |